Ustekinumab has been investigated in patients with psoriasis by randomized clinical trials. There are few data on ustekinumab use under 'real life' conditions outside long-term registries.
Talamonti, M., Galluzzo, M., Bianchi, L., Boca, A., Costanzo, A., Chimenti, S. (2014). What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice. DERMATOLOGY, 229(4), 324-332 [10.1159/000365077].
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice
Talamonti, M;Galluzzo, M;BIANCHI, LUCA;COSTANZO, ANTONIO;CHIMENTI, SERGIO
2014-01-01
Abstract
Ustekinumab has been investigated in patients with psoriasis by randomized clinical trials. There are few data on ustekinumab use under 'real life' conditions outside long-term registries.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
What Happened after the Clinical trial.pdf
solo utenti autorizzati
Descrizione: Articolo principale
Licenza:
Copyright dell'editore
Dimensione
242.66 kB
Formato
Adobe PDF
|
242.66 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
